Terms

Terms of Service

These Terms of Service (“Terms”) govern your access to and use of the RGeneLib website, datasets, and collaboration tools. By using our services, you agree to these Terms.

1. Eligibility & Accounts

You must be at least 18 years old to create an account or request access to secure workspaces. You are responsible for safeguarding login credentials and notifying us of unauthorized use.

2. Acceptable Use

  • • Use information for lawful, ethical purposes aligned with rare disease care, research, or advocacy.
  • • Do not attempt to re-identify individuals, reverse engineer systems, or disrupt platform integrity.
  • • Respect intellectual property rights and attribution requirements for shared resources.

3. Intellectual Property

Content published on the platform, including disease dossiers, research highlights, and design assets, is owned by RGeneLib or its partners. You may cite or share excerpts with proper attribution.

4. Data Collaboration

Collaborative workspaces require separate agreements outlining data governance, authorship, and confidentiality. Participants must comply with applicable ethical approvals and consent requirements.

5. Disclaimers

Our content is for informational purposes only and does not replace professional medical advice. We provide services “as is” without warranties of accuracy, completeness, or availability.

6. Limitation of Liability

To the fullest extent permitted by law, RGeneLib is not liable for indirect, incidental, or consequential damages arising from platform use.

7. Termination

We may suspend or terminate access for violations of these Terms or for security reasons. You may discontinue use at any time.

8. Governing Law & Disputes

These Terms are governed by the laws of the jurisdiction where RGeneLib is incorporated. Disputes will be addressed through good-faith negotiation and, if needed, binding arbitration.

9. Updates

We may update these Terms periodically. Continued use of the platform after updates constitutes acceptance.

Last updated: September 2025